Estriol: Targeted Hormone Therapy for Menopausal Symptom Relief
| Product dosage: 1 g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $29.24 | $29.24 (0%) | 🛒 Add to cart |
| 2 | $27.52 | $58.48 $55.04 (6%) | 🛒 Add to cart |
| 3 | $26.09 | $87.72 $78.26 (11%) | 🛒 Add to cart |
| 4 | $25.16 | $116.96 $100.62 (14%) | 🛒 Add to cart |
| 5 | $23.56
Best per tube | $146.20 $117.82 (19%) | 🛒 Add to cart |
Synonyms | |||
Estriol is a bioidentical estrogen hormone primarily indicated for the management of menopausal symptoms, including vaginal atrophy, dryness, and associated discomfort. As a weak estrogen, it offers a favorable safety profile for localized therapy with minimal systemic absorption when applied topically. It is commonly prescribed as a cream, gel, or suppository for urogenital health, providing effective relief while mitigating risks associated with stronger systemic estrogens.
Features
- Contains estriol, a naturally occurring estrogen (estrogen receptor agonist)
- Available in topical formulations: vaginal cream (0.01%–0.1%), gel, or suppository
- Low systemic absorption when used vaginally
- Bioidentical structure (chemically identical to endogenous human estriol)
- Typically prescribed in micronized form for enhanced bioavailability
- pH-balanced for vaginal application
Benefits
- Effectively relieves symptoms of vaginal atrophy, including dryness, itching, and burning
- Restores vaginal epithelial thickness and improves elasticity
- Reduces the frequency and severity of dyspareunia (painful intercourse)
- Enhances urogenital health by supporting normal flora and pH
- May lower the risk of urinary tract infections in postmenopausal women
- Provides localized relief with limited systemic hormonal effects
Common use
Estriol is predominantly prescribed for the treatment of genitourinary syndrome of menopause (GSM), which encompasses vulvovaginal atrophy, dryness, irritation, and related urinary symptoms. It is also used off-label in compounded preparations for hormonal support in perimenopause, though its systemic efficacy is limited compared to estradiol. Topical estriol is particularly suitable for patients seeking symptom relief without significant systemic estrogen exposure, or for those with contraindications to conventional hormone replacement therapy (HRT).
Dosage and direction
Dosage varies by formulation and indication. For vaginal cream (0.1% estriol), the typical initial dose is 2–4 grams (∼0.2–0.4 mg estriol) applied intravaginally once daily for 2–4 weeks, followed by a maintenance regimen of 1 gram 2–3 times per week. Apply at bedtime for optimal absorption and comfort. Wash hands before and after application. Use the provided applicator for accurate dosing. Dosage should be individualized based on symptom severity and clinical response. Do not exceed prescribed frequency or amount.
Precautions
Patients should undergo a clinical evaluation prior to initiation, including a personal and family medical history. Regular gynecological exams are recommended. Discontinue use if unexplained vaginal bleeding occurs. Topical application may transfer to sexual partners; avoid skin contact during treatment. Use with caution in patients with conditions that may be influenced by estrogen, such as endometriosis, uterine fibroids, or a history of estrogen-sensitive malignancies. Not intended for ophthalmic or oral use.
Contraindications
Estriol is contraindicated in patients with known hypersensitivity to estriol or any component of the formulation. It should not be used in individuals with undiagnosed abnormal genital bleeding, known or suspected estrogen-dependent neoplasia (e.g., breast or endometrial cancer), active or history of venous thromboembolism, active liver disease, or porphyria. Do not use during pregnancy or breastfeeding.
Possible side effect
Common side effects are generally mild and localized, including vaginal irritation, itching, or discharge. Less frequently, patients may experience headache, breast tenderness, abdominal cramping, or nausea. Systemic absorption, though low, may rarely cause estrogenic effects such as bloating, mood changes, or spotting. If severe reactions such as allergic dermatitis, significant bleeding, or signs of thrombosis (e.g., leg pain, shortness of breath) occur, discontinue use and seek medical attention.
Drug interaction
Estriol may interact with other medications, though risk is lower with topical administration. Potential interactions include reduced efficacy with CYP3A4 inducers (e.g., rifampin, St. John’s wort) or enhanced effects with CYP3A4 inhibitors (e.g., ketoconazole). Concurrent use with other estrogen therapies may increase systemic exposure. It may also affect the metabolism of corticosteroids, thyroid hormones, or anticoagulants. Inform your healthcare provider of all medications, including over-the-counter and herbal products.
Missed dose
Apply the missed dose as soon as remembered, unless it is nearly time for the next scheduled dose. Do not double the dose to catch up. Resume the regular dosing schedule. Consistent use is important for optimal therapeutic effect, particularly during the initial treatment phase.
Overdose
Topical overdose is unlikely due to low systemic absorption. Excessive application may lead to heightened local irritation or increased systemic estrogenic effects (e.g., nausea, breast tenderness). In case of accidental ingestion, seek medical attention immediately. Symptomatic and supportive care is recommended; there is no specific antidote.
Storage
Store at room temperature (15–30°C or 59–86°F). Keep the tube tightly closed and away from direct light, moisture, and heat. Do not freeze. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment options, and individualized recommendations. Do not initiate, adjust, or discontinue hormone therapy without medical supervision.
Reviews
Clinical studies and patient reports indicate high satisfaction with estriol for relieving vaginal dryness and discomfort, with many users noting improvement within a few weeks. Its favorable safety profile and localized action make it a preferred option for long-term urogenital health management. Some users report minimal side effects compared to systemic estrogen therapies.